Picture of Atossa Therapeutics logo

ATOS — Atossa Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Atossa Therapeutics - On August 30, Intas Pharmaceuticals Ltd Filed A Petition For Post Grant Review With U.S. Patent And Trademark Office

Aug 31 (Reuters) - Atossa Therapeutics Inc  ATOS.O :
    * ATOSSA THERAPEUTICS -  ON AUGUST 30, INTAS PHARMACEUTICALS
LTD
FILED A PETITION FOR POST GRANT REVIEW WITH U.S. PATENT AND
TRADEMARK OFFICE
    * ATOSSA THERAPEUTICS- INTENDS TO CONTEST PGR PETITION AND
BELIEVES THAT PATENT WAS PROPERLY GRANTED AND IS VALID AND
ENFORCEABLE
    * ATOSSA THERAPEUTICS -  PGR PETITION RELATING TO ONE OF
CO'S
ISSUED PATENTS TITLED, "METHODS FOR MAKING AND USING ENDOXIFEN"

Source: [https://shorturl.at/FHO17]
Further company coverage:  ATOS.O

Recent news on Atossa Therapeutics

See all news